Therefore, GPCR expression profiling was further done in tumors of a well-established transgenic animal model of human HER2+ breast cancer, Neu mice, which express an activated rat ErbB2/HER2 homologue selectively in the mammary gland (24). The gene discussed is ERBB2; the disease is breast cancer.